Abstract:Background: An estimated 1 in 350 women carry germline BRCA1/2 mutations, which confer an increased risk of developing breast and ovarian cancer, and may also contribute to subfertility. All mature, sex steroid-producing ovarian follicles are drawn from the pool of non-renewable primordial follicles, termed the 'ovarian reserve'. The clinical implications of early ovarian reserve exhaustion extend beyond infertility, to include the long-term adverse health consequences of loss of endocrine function and premature menopause. We aimed to determine whether conditional loss of Brca1 in oocytes impacts ovarian follicle numbers, oocyte quality and fertility in mice with advancing maternal age. We also aimed to determine the utility of AMH as a marker of ovarian function, by assessing circulating AMH levels in mice and women with BRCA1/2 mutations, and correlating this with ovarian follicle counts. Methods: In this study, we addressed a longstanding question in the field regarding the functional consequences of BRCA1 inactivation in oocytes. To recapitulate loss of BRCA1 protein function in oocytes, we generated mice with conditional gene deletion of Brca1 in oocytes using Gdf9-Cre recombinase (WT: Brca1fl/flGdf9+/+; cKO: Brca1fl/flGdf9cre/+). Findings: While the length of the fertile lifespan was not altered between groups after a comprehensive breeding trial, conditional loss of Brca1 in oocytes led to reduced litter size in female mice. Brca1 cKO animals had a reduced ovarian reserve and oocyte maturation was impaired with advanced maternal age at postnatal day (PN)300, compared to WT animals. Serum anti-Müllerian hormone (AMH) concentrations (the gold-standard indirect marker of the ovarian reserve used in clinical practice) were not predictive of reduced primordial follicle number in Brca1 cKO mice versus WT. Furthermore, we found no correlation between follicle number or density and serum AMH concentrations in matched samples from a small cohort of premenopausal women with BRCA1/2 mutations. Interpretation: Together, our data demonstrate that BRCA1 is a key regulator of oocyte number and quality in females and suggest that caution should be used in relying on AMH as a reliable marker of the ovarian reserve in this context. Funding: This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. This work was supported by funding from the Australian Research Council (ALW - DE21010037 and KJH - FT190100265), as well as the National Breast Cancer Foundation (IIRS-22-092) awarded to ALW and KJH. LRA, YML, LT, EOKS and MG were supported by Australian Government Research Training Program Scholarships. LRA, YML and LT were also supported by a Monash Graduate Excellence Scholarship. YC, SG and XC were supported by Monash Biomedicine Discovery Institute PhD Scholarships. LRA was also supported by a Monash University ECPF24-6809920940 Fellowship. JMS was supported by NHMRC funding (2011299). MH was supported by an NHMRC Investigator Grant (1193838).

Loss of BMAL1 in ovarian steroidogenic cells results in implantation failure in female mice

Critical Roles of the Circadian Transcription Factor BMAL1 in Reproductive Endocrinology and Fertility

BMAL1 positively correlates with genes regulating steroidogenesis in human luteinized granulosa cells

Loss-of-function mutations with circadian rhythm regulator Per1/Per2 lead to premature ovarian insufficiency†

Bmal1 regulates female reproduction in mice via the hypothalamic-pituitary-ovarian axis

Lack of Bmal1 leads to changes in rhythmicity and impairs motivation towards natural stimuli

Normal Ovarian Function in Subfertile Mouse with Amhr2-Cre-Driven Ablation of Insr and Igf1r

Apparent Absence of BMAL1-Dependent Skeletal Muscle-Kidney Cross Talk in Mice

In Silico, in Vitro, and in Vivo Analysis Identifies Endometrial Circadian Clock Genes in Recurrent Implantation Failure

Conditional loss of Brca1 in oocytes causes reduced litter size, ovarian reserve depletion and impaired oocyte in vitro maturation with advanced reproductive age in mice

Metabolic Profile and Lipid Metabolism Phenotype in Mice with Conditional Deletion of Hepatic BMAL1

BMAL1 Deletion Protects Against Obesity and Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet

Sex differences in the adrenal circadian clock: A role for BMAL1 in the regulation of urinary aldosterone excretion and renal electrolyte balance in mice

Lack of rhythmicity in Bmal1 deficient mice impairs motivation towards natural stimuli

Timing of expression of the core clock gene Bmal1 influences its effects on aging and survival

BMAL1 represses transposable elements independently of CLOCK in pluripotent cells

Defective circadian control in mesenchymal cells reduces adult bone mass in mice by promoting osteoclast function

Deletion of the clock gene Bmal2 leads to alterations in hypothalamic clocks, circadian regulation of feeding and energy balance

Embryonic development and maternal regulation of murine circadian clock function

Beclin-1 deficiency in the murine ovary results in the reduction of progesterone production to promote preterm labor

Maternal Circadian Disruption Before Pregnancy Impairs the Ovarian Function of Female Offspring in Mice.